{"id":1315493,"title":"DSEN Abstract: Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-04","captureTimestamp":"2026-02-04T10:32:02.152000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52735.html","snippet":"DSEN Abstract Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada In 2019, some batches of ranitidine, a readily available histamine H-2 receptor antagonist that counteracts stomach acid, contained an impurity called N-nitrosodimethylamine…","rawSnapshotUrl":"/api/snapshots/raw/1315493","browseUrl":"https://replay.healtharchive.ca/job-8/20260204103202/https://cihr-irsc.gc.ca/e/52735.html#ha_snapshot=1315493","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}